IL148807A0 - Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same - Google Patents
Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL148807A0 IL148807A0 IL14880700A IL14880700A IL148807A0 IL 148807 A0 IL148807 A0 IL 148807A0 IL 14880700 A IL14880700 A IL 14880700A IL 14880700 A IL14880700 A IL 14880700A IL 148807 A0 IL148807 A0 IL 148807A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydrothiopyran
- derivatives
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical class C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99121243 | 1999-10-25 | ||
| US20395000P | 2000-05-12 | 2000-05-12 | |
| PCT/EP2000/010445 WO2001030777A1 (en) | 1999-10-25 | 2000-10-24 | Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL148807A0 true IL148807A0 (en) | 2002-09-12 |
Family
ID=26153155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14880700A IL148807A0 (en) | 1999-10-25 | 2000-10-24 | Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6544993B1 (cs) |
| EP (1) | EP1244654A1 (cs) |
| JP (1) | JP2003512466A (cs) |
| KR (1) | KR20020043238A (cs) |
| CN (1) | CN1146562C (cs) |
| AU (1) | AU781137B2 (cs) |
| BR (1) | BR0014990A (cs) |
| CA (1) | CA2388119A1 (cs) |
| CZ (1) | CZ20021457A3 (cs) |
| EA (1) | EA005856B1 (cs) |
| HK (1) | HK1047276A1 (cs) |
| HR (1) | HRP20020350A2 (cs) |
| HU (1) | HUP0203487A2 (cs) |
| IL (1) | IL148807A0 (cs) |
| MX (1) | MXPA02003581A (cs) |
| NO (1) | NO20021959L (cs) |
| PL (1) | PL354979A1 (cs) |
| SK (1) | SK7232002A3 (cs) |
| TR (1) | TR200201128T2 (cs) |
| WO (1) | WO2001030777A1 (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02003581A (es) * | 1999-10-25 | 2002-10-23 | Altana Pharma Ag | Derivados de ranftalazinona de tetrahidrotiopia como inhibidores pde4. |
| AU2002234634B2 (en) * | 2001-02-15 | 2007-07-26 | Takeda Gmbh | Phthalayinone-piperidino-derivatives as PDE4 inhibitors |
| SK14352003A3 (sk) * | 2001-04-25 | 2004-04-06 | Altana Pharma Ag | Piperazino-deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
| HRP20030868A2 (en) | 2001-04-25 | 2005-08-31 | Altana Pharma Ag | Novel phthalazinones |
| TWI347845B (en) * | 2002-03-06 | 2011-09-01 | Nycomed Gmbh | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same |
| AU2003260371A1 (en) * | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-n-oxide-derivatives |
| EP1537100B1 (en) | 2002-08-10 | 2007-04-25 | ALTANA Pharma AG | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| HRP20050199A2 (hr) * | 2002-08-10 | 2006-04-30 | Altana Pharma Ag | Novi derivati piridazinona |
| AU2003255376A1 (en) * | 2002-08-10 | 2004-03-11 | Altana Pharma Ag | Piperidine-derivatives as pde4 inhibitors |
| RS20050523A (sr) * | 2003-01-14 | 2007-09-21 | Altana Pharma Ag., | Pde4 inhibitori za tretman neoplazmi limfocitnih ćelija |
| WO2005075437A1 (en) * | 2004-02-04 | 2005-08-18 | Altana Pharma Ag | Pyridazinone derivatives and their use as pde4 inhibitors |
| ES2304692T3 (es) * | 2004-02-04 | 2008-10-16 | Nycomed Gmbh | Derivados de 2-(piperidin-4-il)-4,5-dihidro-2h-piridazin-3-ona como inhibidores de pde4. |
| PT2589599E (pt) * | 2004-03-03 | 2014-09-02 | Takeda Gmbh | Novas hidroxi-6-heteroarilfenantridinas e sua utilização como inibidores de pde4 |
| PL2651417T3 (pl) * | 2010-12-16 | 2017-08-31 | Calchan Limited | Pochodne pirolopirymidyny hamujące ASK1 |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| NZ712180A (en) | 2013-03-13 | 2017-01-27 | Flatley Discovery Lab Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9204808D0 (en) * | 1992-03-04 | 1992-04-15 | Rhone Poulenc Rorer Ltd | Novel compositions of matter |
| PL309257A1 (en) | 1992-12-02 | 1995-10-02 | Pfizer | Pirocatechin doethers as selective inhibitors of ped iv |
| DE19533975A1 (de) | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
| WO1998031674A1 (en) * | 1997-01-15 | 1998-07-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phthalazinones |
| WO1999031071A1 (en) | 1997-12-15 | 1999-06-24 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New phthalazinones |
| IL136359A (en) * | 1997-12-15 | 2003-03-12 | Byk Gulden Lomberg Chem Fab | Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same |
| JP2002506856A (ja) | 1998-03-14 | 2002-03-05 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | フタラジノンｐｄｅｉｉｉ／ｉｖ阻害剤 |
| MXPA02003581A (es) * | 1999-10-25 | 2002-10-23 | Altana Pharma Ag | Derivados de ranftalazinona de tetrahidrotiopia como inhibidores pde4. |
-
2000
- 2000-10-24 MX MXPA02003581A patent/MXPA02003581A/es unknown
- 2000-10-24 US US10/110,397 patent/US6544993B1/en not_active Expired - Fee Related
- 2000-10-24 HK HK02108822.5A patent/HK1047276A1/zh unknown
- 2000-10-24 IL IL14880700A patent/IL148807A0/xx unknown
- 2000-10-24 KR KR1020027005200A patent/KR20020043238A/ko not_active Withdrawn
- 2000-10-24 AU AU15151/01A patent/AU781137B2/en not_active Ceased
- 2000-10-24 WO PCT/EP2000/010445 patent/WO2001030777A1/en not_active Ceased
- 2000-10-24 SK SK723-2002A patent/SK7232002A3/sk unknown
- 2000-10-24 TR TR2002/01128T patent/TR200201128T2/xx unknown
- 2000-10-24 HR HR20020350A patent/HRP20020350A2/hr not_active Application Discontinuation
- 2000-10-24 CA CA002388119A patent/CA2388119A1/en not_active Abandoned
- 2000-10-24 PL PL00354979A patent/PL354979A1/xx not_active Application Discontinuation
- 2000-10-24 JP JP2001533131A patent/JP2003512466A/ja active Pending
- 2000-10-24 EP EP00977429A patent/EP1244654A1/en not_active Withdrawn
- 2000-10-24 BR BR0014990-0A patent/BR0014990A/pt not_active IP Right Cessation
- 2000-10-24 HU HU0203487A patent/HUP0203487A2/hu unknown
- 2000-10-24 CN CNB008146977A patent/CN1146562C/zh not_active Expired - Fee Related
- 2000-10-24 CZ CZ20021457A patent/CZ20021457A3/cs unknown
- 2000-10-24 EA EA200200381A patent/EA005856B1/ru not_active IP Right Cessation
-
2002
- 2002-04-25 NO NO20021959A patent/NO20021959L/no not_active Application Discontinuation
-
2003
- 2003-02-25 US US10/372,243 patent/US6846821B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL354979A1 (en) | 2004-03-22 |
| CA2388119A1 (en) | 2001-05-03 |
| AU1515101A (en) | 2001-05-08 |
| SK7232002A3 (en) | 2002-09-10 |
| HK1047276A1 (zh) | 2003-02-14 |
| BR0014990A (pt) | 2002-06-18 |
| HUP0203487A2 (hu) | 2003-02-28 |
| CN1382137A (zh) | 2002-11-27 |
| NO20021959D0 (no) | 2002-04-25 |
| EA005856B1 (ru) | 2005-06-30 |
| AU781137B2 (en) | 2005-05-05 |
| NO20021959L (no) | 2002-05-29 |
| JP2003512466A (ja) | 2003-04-02 |
| EP1244654A1 (en) | 2002-10-02 |
| US6544993B1 (en) | 2003-04-08 |
| CZ20021457A3 (cs) | 2002-07-17 |
| KR20020043238A (ko) | 2002-06-08 |
| HRP20020350A2 (en) | 2004-02-29 |
| MXPA02003581A (es) | 2002-10-23 |
| TR200201128T2 (tr) | 2002-08-21 |
| US20030166655A1 (en) | 2003-09-04 |
| US6846821B2 (en) | 2005-01-25 |
| WO2001030777A1 (en) | 2001-05-03 |
| CN1146562C (zh) | 2004-04-21 |
| EA200200381A1 (ru) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24066A (en) | Novel quinuclidine derivatives and medicinal compositions containing the same | |
| IL149757A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing the same | |
| IL144977A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL138899A0 (en) | Amidene derivatives and pharmaceutical compositions containing the same | |
| IL202633A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
| IL140862A (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the same | |
| IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
| HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
| IL146540A0 (en) | Thiazolo derivatives and pharmaceutical compositions containing them | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL150734A0 (en) | Azaindole derivatives and pharmaceutical compositions containing the same | |
| IL143920A0 (en) | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same | |
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| IL138572A0 (en) | Benzoate derivatives and pharmaceutical compositions containing the same |